Literature DB >> 33139939

Phosphatidylinositol-3-OH kinase signalling is spatially organized at endosomal compartments by microtubule-associated protein 4.

Narendra Thapa1, Mo Chen1, Hudson T Horn1, Suyong Choi1, Tianmu Wen1, Richard A Anderson2.   

Abstract

The canonical model of agonist-stimulated phosphatidylinositol-3-OH kinase (PI3K)-Akt signalling proposes that PI3K is activated at the plasma membrane, where receptors are activated and phosphatidylinositol-4,5-bisphosphate is concentrated. Here we show that phosphatidylinositol-3,4,5-trisphosphate generation and activated Akt are instead largely confined to intracellular membranes upon receptor tyrosine kinase activation. Microtubule-associated protein 4 (MAP4) interacts with and controls localization of membrane vesicle-associated PI3Kα to microtubules. The microtubule-binding domain of MAP4 binds directly to the C2 domain of the p110α catalytic subunit. MAP4 controls the interaction of PI3Kα with activated receptors at endosomal compartments along microtubules. Loss of MAP4 results in the loss of PI3Kα targeting and loss of PI3K-Akt signalling downstream of multiple agonists. The MAP4-PI3Kα assembly defines a mechanism for spatial control of agonist-stimulated PI3K-Akt signalling at internal membrane compartments linked to the microtubule network.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33139939     DOI: 10.1038/s41556-020-00596-4

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  63 in total

Review 1.  The PI3K Pathway in Human Disease.

Authors:  David A Fruman; Honyin Chiu; Benjamin D Hopkins; Shubha Bagrodia; Lewis C Cantley; Robert T Abraham
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

Review 2.  Signalling specificity in the Akt pathway in breast cancer.

Authors:  Abbe R Clark; Alex Toker
Journal:  Biochem Soc Trans       Date:  2014-10       Impact factor: 5.407

Review 3.  The Hidden Conundrum of Phosphoinositide Signaling in Cancer.

Authors:  Narendra Thapa; Xiaojun Tan; Suyong Choi; Paul F Lambert; Alan C Rapraeger; Richard A Anderson
Journal:  Trends Cancer       Date:  2016-06-20

4.  A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.

Authors:  Yiqun Zhang; Patrick Kwok-Shing Ng; Melanie Kucherlapati; Fengju Chen; Yuexin Liu; Yiu Huen Tsang; Guillermo de Velasco; Kang Jin Jeong; Rehan Akbani; Angela Hadjipanayis; Angeliki Pantazi; Christopher A Bristow; Eunjung Lee; Harshad S Mahadeshwar; Jiabin Tang; Jianhua Zhang; Lixing Yang; Sahil Seth; Semin Lee; Xiaojia Ren; Xingzhi Song; Huandong Sun; Jonathan Seidman; Lovelace J Luquette; Ruibin Xi; Lynda Chin; Alexei Protopopov; Thomas F Westbrook; Carl Simon Shelley; Toni K Choueiri; Michael Ittmann; Carter Van Waes; John N Weinstein; Han Liang; Elizabeth P Henske; Andrew K Godwin; Peter J Park; Raju Kucherlapati; Kenneth L Scott; Gordon B Mills; David J Kwiatkowski; Chad J Creighton
Journal:  Cancer Cell       Date:  2017-05-18       Impact factor: 31.743

Review 5.  PI3K and cancer: lessons, challenges and opportunities.

Authors:  David A Fruman; Christian Rommel
Journal:  Nat Rev Drug Discov       Date:  2014-02       Impact factor: 84.694

Review 6.  Phosphoinositide spatially free AKT/PKB activation to all membrane compartments.

Authors:  Narendra Thapa; Hudson Tyler Horn; Richard A Anderson
Journal:  Adv Biol Regul       Date:  2019-04-11

Review 7.  Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors.

Authors:  Patricia Mucci LoRusso
Journal:  J Clin Oncol       Date:  2016-09-30       Impact factor: 44.544

Review 8.  Phosphoinositides: tiny lipids with giant impact on cell regulation.

Authors:  Tamas Balla
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

Review 9.  Structural basis for activation and inhibition of class I phosphoinositide 3-kinases.

Authors:  Oscar Vadas; John E Burke; Xuxiao Zhang; Alex Berndt; Roger L Williams
Journal:  Sci Signal       Date:  2011-10-18       Impact factor: 8.192

Review 10.  Synergy in activating class I PI3Ks.

Authors:  John E Burke; Roger L Williams
Journal:  Trends Biochem Sci       Date:  2015-01-05       Impact factor: 13.807

View more
  12 in total

1.  IQGAP1 scaffolding links phosphoinositide kinases to cytoskeletal reorganization.

Authors:  V Siddartha Yerramilli; Alonzo H Ross; Suzanne Scarlata; Arne Gericke
Journal:  Biophys J       Date:  2022-01-22       Impact factor: 4.033

2.  A p53-phosphoinositide signalosome regulates nuclear AKT activation.

Authors:  Vincent L Cryns; Richard A Anderson; Mo Chen; Suyong Choi; Tianmu Wen; Changliang Chen; Narendra Thapa; Jeong Hyo Lee
Journal:  Nat Cell Biol       Date:  2022-07-07       Impact factor: 28.213

3.  Pulling back the curtain: The hidden functions of receptor tyrosine kinases in development.

Authors:  James F Clark; Philippe M Soriano
Journal:  Curr Top Dev Biol       Date:  2022-02-28       Impact factor: 5.242

4.  Troxerutin alleviates kidney injury in rats via PI3K/AKT pathway by enhancing MAP4 expression.

Authors:  Tongxu Guan; Yingce Zheng; Shengzi Jin; Shuang Wang; Mengxin Hu; Xingyao Liu; Siqi Huang; Yun Liu
Journal:  Food Nutr Res       Date:  2022-05-24       Impact factor: 3.221

Review 5.  Modulation of Pathological Pain by Epidermal Growth Factor Receptor.

Authors:  Jazlyn P Borges; Katrina Mekhail; Gregory D Fairn; Costin N Antonescu; Benjamin E Steinberg
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

6.  Fyn and TOM1L1 are recruited to clathrin-coated pits and regulate Akt signaling.

Authors:  Rebecca Cabral-Dias; Stefanie Lucarelli; Karolina Zak; Sadia Rahmani; Gurjeet Judge; John Abousawan; Laura F DiGiovanni; Dafne Vural; Karen E Anderson; Michael G Sugiyama; Gizem Genc; Wanjin Hong; Roberto J Botelho; Gregory D Fairn; Peter K Kim; Costin N Antonescu
Journal:  J Cell Biol       Date:  2022-03-03       Impact factor: 8.077

Review 7.  Activation Mechanisms of the VPS34 Complexes.

Authors:  Yohei Ohashi
Journal:  Cells       Date:  2021-11-11       Impact factor: 7.666

8.  Endosomal mTORC2 Is Required for Phosphoinositide-Dependent AKT Activation in Platelet-Derived Growth Factor-Stimulated Glioma Cells.

Authors:  Suree Kim; Sukyeong Heo; Joseph Brzostowski; Dongmin Kang
Journal:  Cancers (Basel)       Date:  2021-05-16       Impact factor: 6.639

Review 9.  Endosomes as Signaling Platforms for IL-6 Family Cytokine Receptors.

Authors:  Dirk Schmidt-Arras; Stefan Rose-John
Journal:  Front Cell Dev Biol       Date:  2021-06-01

Review 10.  Revising Endosomal Trafficking under Insulin Receptor Activation.

Authors:  Maria J Iraburu; Tommy Garner; Cristina Montiel-Duarte
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.